268 Drug persistence and compliance affecting patient reported outcomes in overactive bladder syndrome patient

European Urology Supplements ◽

10.1016/s1569-9056(15)60265-2 ◽

2015 ◽

Vol 14 (2) ◽

pp. e268

Author(s):

T.H. Kim ◽

M.S. Choo ◽

K-S. Lee

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Overactive Bladder Syndrome ◽

Syndrome Patient ◽

Patient Reported

Download Full-text

1006 TREATING PATIENTS' MOST BOTHERSOME SYMPTOM OF OVERACTIVE BLADDER SYNDROME: PATIENT-REPORTED OUTCOMES FROM A LARGE OPEN-LABEL TRIAL OF SOLIFENACIN

European Urology Supplements ◽

10.1016/s1569-9056(07)61001-x ◽

2007 ◽

Vol 6 (2) ◽

pp. 274

Author(s):

W. Steers ◽

M. Andoh ◽

S. Forero-Schwanhaeuser

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Overactive Bladder Syndrome ◽

Syndrome Patient ◽

Patient Reported ◽

Bothersome Symptom ◽

Open Label Trial

Download Full-text

1959 MIRABEGRON IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME - RESULTS FROM A NORTH-AMERICAN STUDY

The Journal of Urology ◽

10.1016/j.juro.2011.02.2163 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Victor Nitti ◽

Sender Herschorn ◽

Stephen Auerbach ◽

Nancy Martin ◽

Mary Beth Blauwet ◽

...

Keyword(s):

Overactive Bladder ◽

North American ◽

Patient Reported Outcomes ◽

Overactive Bladder Syndrome ◽

American Study ◽

North American Study ◽

Patient Reported

Download Full-text

Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome

Quality of Life Research ◽

10.1007/s11136-015-1216-z ◽

2015 ◽

Vol 25 (8) ◽

pp. 2021-2029 ◽

Author(s):

Tae Heon Kim ◽

Myung-Soo Choo ◽

Young-Joo Kim ◽

Hyein Koh ◽

Kyu-Sung Lee

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Overactive Bladder Syndrome ◽

Patient Reported

Download Full-text

Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms

International Neurourology Journal ◽

10.5213/inj.1624678.339 ◽

2016 ◽

Vol 20 (4) ◽

pp. 349-355

Author(s):

Kyu Shik Kim ◽

Hong Sang Moon

Keyword(s):

Depressive Symptoms ◽

Overactive Bladder ◽

Patient Reported Outcomes ◽

Overactive Bladder Syndrome ◽

Antimuscarinic Agent ◽

Patient Reported ◽

Agent Treatment

Download Full-text

Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)

Advances in Therapy ◽

10.1007/s12325-019-00994-7 ◽

2019 ◽

Vol 36 (8) ◽

pp. 1906-1921 ◽

Author(s):

Kevin V. Carlson ◽

Eric S. Rovner ◽

Kavita V. Nair ◽

Anna S. Deal ◽

Rita M. Kristy ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Overactive Bladder Syndrome ◽

Registry Study ◽

Factors Associated ◽

Patient Reported ◽

Study Perspective

Download Full-text

Faculty Opinions recommendation of Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726641973.793540485 ◽

2017 ◽

Author(s):

Lori Ann Birder

Keyword(s):

Overactive Bladder ◽

Phase Ii ◽

Combination Treatment ◽

Patient Reported Outcomes ◽

Phase Ii Study ◽

Double Blind ◽

Patient Reported ◽

Download Full-text

A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments

Neurourology and Urodynamics ◽

10.1002/nau.23271 ◽

2017 ◽

Vol 37 (1) ◽

pp. 177-185 ◽

Author(s):

Suvapun Bunniran ◽

Cralen Davis ◽

Rita Kristy ◽

Daniel Ng ◽

Carol R. Schermer ◽

...

Keyword(s):

Overactive Bladder ◽

Prospective Study ◽

Patient Reported Outcomes ◽

Patient Reported ◽

A Prospective Study

Download Full-text

Solifenacin for Overactive Bladder: Patient-Reported Outcomes from a Large Placebo-Controlled Trial

Postgraduate Medicine ◽

10.3810/pgm.2009.09.2062 ◽

2009 ◽

Vol 121 (5) ◽

pp. 151-158 ◽

Author(s):

Marc R. Toglia ◽

Scott R. Serels ◽

Christine Laramee ◽

Mickey M. Karram ◽

Indrani M. Nandy ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Patient Reported

Download Full-text

190 SOLIFENACIN SIGNIFICANTLY IMPROVES OVERACTIVE BLADDER (OAB) SYMPTOMS, SYMPTOM-ASSOCIATED BOTHER AND OTHER PATIENT-REPORTED OUTCOMES: RESULTS FROM VIBRANT, A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(09)60195-0 ◽

2009 ◽

Vol 8 (4) ◽

pp. 168 ◽

Author(s):

T.A. Samuels ◽

H.D. Mitcheson ◽

M.D. Vardy ◽

S. Forero-Schwanhaeuser ◽

T. Marshall ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Patient Reported

Download Full-text

Patient Reported Outcomes(Pros) in Patients with Lower Urinary Track Symptom(Luts)/Benign Prostatic Hyperplasia(Bph) Accompanied with Overactive Bladder(Oab) in Korea

Value in Health ◽

10.1016/j.jval.2014.08.561 ◽

2014 ◽

Vol 17 (7) ◽

pp. A812

Author(s):

J.Y. Lee ◽

Y.H. Park ◽

Y.J. Kim

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Patient Reported Outcomes ◽

Prostatic Hyperplasia ◽

Patient Reported ◽

Download Full-text